Barinthus Biotherapeutics Stock Quote BRNS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.87

Bid

0.85

Ask

0.974

Volume

10,862

0.8561 Day's Range 0.94

0.00 52 Week Range 0.00

Market Cap

35.095M

Previous Close

0.88

Open

0.94

Last Trade

0.8501

Last Trade Time

Financial Volume

$ 9,666

VWAP

0.889928

Average Volume (3m)

Shares Outstanding

40,339,395

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

16.15M

Net Profit

-61.07M

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases and autoimmunity. Its pipeline, built around platform technologies; viral vector-based, consist... Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases and autoimmunity. Its pipeline, built around platform technologies; viral vector-based, consists of ChAdOx and MVA, and synthetic, consisting of SNAP-Tolerance Immunotherapy (SNAP-TI). These platforms help to develop antigen-specific immunotherapeutic candidates designed to optimize the disease fighting capabilities of T cells and guide them towards a healthy balance. It is focused on developing two key product candidates that harness its viral vector and synthetic platform technologies. These include VTP-300, a Phase II immunotherapeutic candidate designed as a potential component of a functional cure for chronic hepatitis B virus infection utilizing ChAdOx/MVA, and VTP-1000, its autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.barinthusbio.com/

Headquarters

Oxfordshire, Gbr

Founded

Barinthus Biotherapeutics PLC is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker BRNS. The last closing price for Barinthus Biotherapeutics was $0.88. Over the last year, Barinthus Biotherapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Barinthus Biotherapeutics currently has 40,339,395 shares outstanding. The market capitalization of Barinthus Biotherapeutics is $35.50 million.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

BRNS - Frequently Asked Questions (FAQ)

What is the current Barinthus Biotherapeutics share price?

The current share price of Barinthus Biotherapeutics is $ 0.87

How many Barinthus Biotherapeutics shares are in issue?

Barinthus Biotherapeutics has 40,339,395 shares in issue

What is the market cap of Barinthus Biotherapeutics?

The market capitalisation of Barinthus Biotherapeutics is USD 35.5M

What is the 1 year trading range for Barinthus Biotherapeutics share price?

Barinthus Biotherapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the reporting currency for Barinthus Biotherapeutics?

Barinthus Biotherapeutics reports financial results in USD

What is the latest annual turnover for Barinthus Biotherapeutics?

The latest annual turnover of Barinthus Biotherapeutics is USD 16.15M

What is the latest annual profit for Barinthus Biotherapeutics?

The latest annual profit of Barinthus Biotherapeutics is USD -61.07M

What is the registered address of Barinthus Biotherapeutics?

The registered address for Barinthus Biotherapeutics is UNIT 6-10, ZEUS BUILDING, RUTHERFORD AVENUE, HARWELL, OXFORDSHIRE, OX11 0DF

What is the Barinthus Biotherapeutics website address?

The website address for Barinthus Biotherapeutics is www.barinthusbio.com/

Which industry sector does Barinthus Biotherapeutics operate in?

Barinthus Biotherapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NWGLNature Wood Group Ltd	$ 5.615 (142.03%)	5.98M
KWEKWESST Micro Systems Inc	$ 11.2296 (94.96%)	37.36M
PTLEPTL Ltd	$ 0.3656 (84.74%)	404.15M
APVOAptevo Therapeutics Inc	$ 5.01 (77.66%)	124.47M
MRINMarin Software Incorporated	$ 1.435 (68.82%)	50.06M
CBIOCrescent Biopharma Inc	$ 14.60 (-71.45%)	97.59k
CEROCERo Therapeutics Holdings Inc	$ 11.5501 (-41.75%)	3.03M
BMEABiomea Fusion Inc	$ 1.90 (-34.48%)	11.66M
PSTVPlus Therapeutics Inc	$ 0.2025 (-34.38%)	23.9M
CONIGraniteShares ETF Trust 2X Short COIN Daily ETF	$ 3.7198 (-32.49%)	21.46M
HCTIHealthcare Triangle Inc	$ 0.0265 (19.91%)	455.2M
PTLEPTL Ltd	$ 0.3656 (84.74%)	404.15M
GNLNGreenlane Holdings Inc	$ 0.01035 (-0.48%)	260.94M
NVDANVIDIA Corporation	$ 145.48 (0.94%)	161.49M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.365 (3.56%)	141.16M